SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Myriad Genetics Inc. (MYGN) on Tuesday reported a loss of $26 million in its first quarter.
The Salt Lake City-based company said it had a loss of 29 cents per share. Losses, adjusted for non-recurring costs and stock option expense,...
